Gene Therapies. New Payment Models. FDA Approval Standards.

 

CONFIRMED SPEAKERS

JOE GROGAN (WHITE HOUSE)

SCOTT GOTTLIEB (AEI)

STEVE PEARSON (ICER)

JANET WOODCOCK (FDA)

GIDEON BLUMENTHAL (FDA) 

PETER MARKS (FDA)

BOB TEMPLE (FDA)

PAUL KLUETZ (FDA)

WILSON BRYAN (FDA)

HYLTON JOFFE (FDA)

TIFFANY FARCHIONE (FDA)

AMY HALL (HOUSE WAYS & MEANS) 

ELLIOT LEVY (AMGEN)

JEREMY ALLEN (SPARK)

SYMANTHA MELEMED (ELI LILLY)

REKHA RAMESH (GILEAD)

CHRISTOPH GLAETZER (J&J)

RACHEL SHERMAN (DUKE-MARGOLIS)

JOHN O’BRIEN (FORMER HHS)

STEPHANIE FARNIA (BLUE CROSS BLUE SHIELD)

DAVID MITCHELL (Patients for affordable drugs)

CO-PRODUCED BY PREVISION POLICY + FRIENDS OF CANCER RESEARCH

 
 
 

LEAD 2019 BIOPHARMA CONGRESS SPONSOR

 

2019 INDUSTRY SPONSORS

 
 
 
 
 
 
 

agenda

view our agenda of regulators, policy makers, and drug developers

Learn More →

Register

space is limited. register now.

Find Out How →